Auna S A Revenue Growth Rates (AUNA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Auna S a   (NYSE: AUNA)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

AUNA's Revenue Growth by Quarter and Year

Auna S A 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AUNA Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 1,328.75
3rd Quarter September 0.00
2nd Quarter June 302.03
1st Quarter March 0.00
FY 1,630.78





AUNA Revenue fourth quarter 2025 Y/Y Growth Comment
Auna S a achieved in the fourth quarter 2025, above Company average Revenue surge of 340.26% year on year, to $ 1,328.75 millions.

According to the results reported in the fourth quarter 2025, Auna S A achieved the best Revenue growth in Healthcare Facilities industry. While Auna S A ' s Revenue doubling of 340.26% ranks overall at the positon no. 203 in the fourth quarter 2025.


AUNA Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 340.26 % - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   440.33 % - - -

Financial Statements
Auna S A 's fourth quarter 2025 Revenue $ 1,328.75 millions AUNA's Income Statement
Auna S A 's fourth quarter 2024 Revenue $ 301.81 millions Quarterly AUNA's Income Statement


AUNA Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   440.33 % - - -


Back to AUNA Growth rate Comparisons >> Back to AUNA Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #53
Overall #203

Revenue Y/Y Growth Statistics
High Average Low
106.48 % 106.48 % 106.48 %
(Dec 31 2025)  
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #53
Overall #203
Revenue Y/Y Growth Statistics
High Average Low
106.48 % 106.48 % 106.48 %
(Dec 31 2025)  

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Auna S A 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AUNA's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AUNA's IV. Quarter Q/Q Revenue Comment


Auna S A 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
 12 Months Ending
 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 1,328.75 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) 12.72 % - - - -
Year on Year Revenue Growth Overall Ranking # 203 # 0 # # #
Seqeuential Revenue Change (TTM) 12.72 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 203 # 0 # # #


Cumulative Revenue growth Comment
Although Auna S A 's Annual Revenue growth year on year were below company's average 106.48% , Revenue announced in the Dec 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 12.72% year on year, from % in . And, Auna S A had the highest Revenue growth, in Healthcare Facilities industry.

In the Healthcare sector 52 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 203.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 1
Healthcare Sector # 53
Overall # 203

Revenue TTM Y/Y Growth Statistics
High Average Low
106.48 %
 106.48 %
106.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 53
S&P 500 # 203
Cumulative Revenue growth Comment
Although Auna S A 's Annual Revenue growth year on year were below company's average 106.48% , Revenue announced in the Dec 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 12.72% year on year, from % in . And, Auna S A had the highest Revenue growth, in Healthcare Facilities industry.

In the Healthcare sector 52 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 203.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 1
Healthcare Sector # 53
Overall # 203

Revenue TTM Y/Y Growth Statistics
High Average Low
106.48 %
106.48 %
106.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 53
S&P 500 # 203




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AUNA's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Lightwave Logic Inc 594.54%$ 594.537 millions
Vaxart Inc 586.46%$ 586.460 millions
Abeona Therapeutics Inc 581.04%$ 581.036 millions
Humacyte Inc 558.35%$ 558.354 millions
Nuvation Bio Inc 544.57%$ 544.573 millions
Nexalin Technology Inc 532.46%$ 532.455 millions
Seastar Medical Holding Corp526.87%$ 526.866 millions
Assembly Biosciences Inc 477.26%$ 477.260 millions
Renovorx Inc 453.49%$ 453.488 millions
Legend Biotech Corporation451.62%$ 451.624 millions
Capforce Inc 424.00%$ 424.000 millions
Altimmune inc 420.00%$ 420.000 millions
Vir Biotechnology Inc 417.78%$ 417.779 millions
Cg Oncology Inc 409.21%$ 409.211 millions
Immunitybio inc 406.95%$ 406.952 millions
Aspira Women s Health inc 385.61%$ 385.609 millions
Intercure Ltd 318.38%$ 318.385 millions
Vireo Growth Inc.317.81%$ 317.813 millions
Cormedix Inc 312.10%$ 312.097 millions
Galapagos Nv303.50%$ 303.502 millions
Insmed Inc287.83%$ 287.825 millions
Tscan Therapeutics Inc 286.02%$ 286.015 millions
Beam Therapeutics Inc 279.52%$ 279.516 millions
Meiragtx Holdings Plc252.33%$ 252.333 millions
Star Equity Holdings Inc 232.22%$ 232.220 millions
Ethema Health Corporation 228.03%$ 228.030 millions
Foghorn Therapeutics Inc 223.77%$ 223.775 millions
Madrigal Pharmaceuticals Inc 210.77%$ 210.766 millions
Biocryst Pharmaceuticals Inc 209.09%$ 209.087 millions
Prenetics Global Limited201.94%$ 201.941 millions


About Auna S A Revenue Growth Rates (AUNA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Auna S A (CIK 1799207).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-168210
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Auna S A’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.